Start main content

Cancer Stem-cell Therapeutics Limited

Cancer Stem-cell Therapeutics Limited

Cancer Stem-cell Therapeutics Limited

Cancer stem-cell therapeutics Limited, also known as CAST, is a Hong Kong biotech company aiming at developing novel cancer treatments by targeting the hardest-to-treat cancer stem cells using their patented technology.  They strive to improve patients' survival and quality of life. Their innovative and insightful technologies focus on minimizing recurrence and metastasis and provide better options for patients. The company will apply their frontier technology to other cancer types and treatment regimes in the future.

Team Member(s)
SUN Gege (Department of Applied Biology and Chemical Technology)
CHOW Ming Cheung (Department of Applied Biology and Chemical Technology)
WONG Lai King (Department of Applied Biology and Chemical Technology)
CHAN Tak Hang (Department of Applied Biology and Chemical Technology)

 

Sign up to receive our e-publications.

We use Cookies to give you a better experience on our website. By continuing to browse the site without changing your privacy settings, you are consenting to our use of Cookies. For more information, please see our Privacy Policy Statement.

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here